CEO Council for Growth's Executive Director Claire Greenwood submitted this letter to the editor in The Philadelphia Inquirer to emphasize the importance of investing in this sector to support the growth of our region.
For the nearly 5,000 employees working cell & gene therapy who call Philadelphia home, it has proven to be the best of both worlds with attributes that satisfy both your personal and professional life.
Claire Greenwood, Executive Director, CEO Council for Growth, and Patricia Day, Manager, Leadership Engagement, the Chamber of Commerce for Greater Philadelphia elaborate on the creation of the Life Science Talent Pipeline Collaborative in an op-ed originally published at CellandGene.com.
The critically important work of the life sciences industry globally has been front and center as health care providers, researchers, manufacturers and distributors collaborate to respond to the coronavirus pandemic.
The Greater Philadelphia region’s reputation as a center for the cell and gene therapy industry grew in 2020 as breakthrough research from industry academia pioneers is increasingly complemented by strong capital investment and real estate projects meeting the specialized land, building, and lab development needs of start-up, scaling and relocating companies.
Investment
According to research from biopharma database company DealForma (as of December 9, 2020), the Greater Philadelphia region saw 49 life sciences investment deals in 2020, valued at more than $12 billion, including six in the cell and gene therapy space totaling $4.5 billion. Among the cell and gene therapy investment […]
PHILADELPHIA (December 17, 2020) – The Greater Philadelphia region’s reputation as a center for the cell and gene therapy and connected health industries grew in 2020, driven by breakthrough research from industry pioneers, strong capital investment, and real estate projects meeting specialized land, building, and lab development needs for start-up, scaling and relocating companies. Further evidence of the momentum comes from a workforce talent study announced this year that predicts strong growth over the coming decade for the sectors.
According to research from biopharma database company DealForma (as of December 9, 2020), the Greater Philadelphia region saw 49 life sciences investment […]
Partners in Greater Philadelphia’s Cell & Gene Therapy and Connected Health Initiative continue to make significant contributions to the response to SARS-CoV-2, impacting human health not just regionally, but globally as well. The Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth has compiled a list of just some of the recent research and development contributions made by its partners in the Initiative. The round-up includes research updates from Penn Medicine on vaccine development; Children’s Hospital of Philadelphia on COVID-19 tracking; ChristianaCare on gene editing; and Aramark on the creation of a workplace safety digital product.
Penn Medicine […]
The Philadelphia Metro area is ranked number six among top life sciences clusters in the U.S. in the JLL 2020 U.S. Life Sciences Outlook, which was released on July 28. The placement for the region is an increase over the 2019 report, which listed Philadelphia at number eight. JLL, a leading professional services firm that specializes in real estate and investment management, profiles the nation’s top life sciences hubs in the annual report, and tracks progress of up-and-coming life sciences markets. In the Philadelphia Metro Area’s profile, JLL noted new peaks in venture capital funding and life sciences employment.
“Each cluster […]
Greater Philadelphia is a center of excellence in cell and gene therapies. This article originally appeared in Site Selection Magazine's July 2020 edition.
PHILADELPHIA (May 8, 2020) – Greater Philadelphia’s health care, science, and research institutions have quickly shifted resources and priorities to mobilize and make a difference in the fight against COVID-19. From working to develop a vaccine against SARS-CoV-2 to investigating the capacity of CRISPR molecules to diagnose or treat COVID-19, the health care and life sciences community is making significant contributions to the COVID-19 response. Educational institutions and corporations are also employing technology to benefit frontline health care workers as they engineer, collect, and donate personal protective equipment including masks and respirators. Connected health technology is rapidly expanding, and companies […]
